Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1972 Oct;6(4):465–468. doi: 10.1128/iai.6.4.465-468.1972

Herpesvirus hominis Type 2 Infections in Rabbits: Effect of Prior Immunization with Attenuated Mycobacterium bovis (BCG) Cells

C L Larson 1,2, R N Ushijima 1,2, R Karim 1,2, M B Baker 1,2, R E Baker 1,2
PMCID: PMC422560  PMID: 4344024

Abstract

Angora, New Zealand, and Dutch-belted rabbits were tested for their susceptibility to graded doses of Herpesvirus hominis type 2 administered by vaginal instillation, intracorneal injection, and scarification of the cornea. Central nervous system involvement and death occurred after infection by the various routes employed. Prior immunization of Dutch-belted and New Zealand rabbits with viable Mycobacterium bovis (BCG) cells injected intravenously provided protection against subsequent infections with type 2 virus.

Full text

PDF
465

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blanden R. V. Increased antibacterial resistance and immunodepression during graft-versus-host reactions in mice. Transplantation. 1969 Jun;7(6):484–497. doi: 10.1097/00007890-196906000-00005. [DOI] [PubMed] [Google Scholar]
  2. Brehmer W., Anacker R. L., Ribi E. Immunogenicity of cell walls from various mycobacteria against airborne tuberculosis in mice. J Bacteriol. 1968 Jun;95(6):2000–2004. doi: 10.1128/jb.95.6.2000-2004.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Claflin J. L., Larson C. L. Infection-immunity in tularemia: specificity of cellular immunity. Infect Immun. 1972 Mar;5(3):311–318. doi: 10.1128/iai.5.3.311-318.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coleman V. R., Tsu E., Jawetz E. "Treatment-resistance" to idoxuridine in herpetic keratitis. Proc Soc Exp Biol Med. 1968 Dec;129(3):761–765. doi: 10.3181/00379727-129-33419. [DOI] [PubMed] [Google Scholar]
  5. Collins F. M. Recall of immunity in mice vaccinated with Salmonella enteritidis or Salmonella typhimurium. J Bacteriol. 1968 Jun;95(6):2014–2021. doi: 10.1128/jb.95.6.2014-2021.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hirsch M. S., Zisman B., Allison A. C. Macrophages and age-dependent resistance to Herpes simplex virus in mice. J Immunol. 1970 May;104(5):1160–1165. [PubMed] [Google Scholar]
  7. Koster F. T., McGregor D. D., Mackaness G. B. The mediator of cellular immunity. II. Migration of immunologically committed lymphocytes into inflammatory exudates. J Exp Med. 1971 Feb 1;133(2):400–409. doi: 10.1084/jem.133.2.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LARSON C. L., WICHT W. C. Studies of resistance to experimental tuberculosis in mice vaccinated with living attenuated tubercle bacilli and challenged with virulent organisms. Am Rev Respir Dis. 1962 Jun;85:833–846. doi: 10.1164/arrd.1962.85.6.833. [DOI] [PubMed] [Google Scholar]
  9. Mackaness G. B., Blanden R. V. Cellular immunity. Prog Allergy. 1967;11:89–140. [PubMed] [Google Scholar]
  10. Mackaness G. B. Cellular immunity. Ann Inst Pasteur (Paris) 1971 Mar;120(3):428–437. [PubMed] [Google Scholar]
  11. Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McGregor D. D., Koster F. T., Mackaness G. B. The mediator of cellular immunity. I. The life-span and circulation dynamics of the immunologically committed lymphocyte. J Exp Med. 1971 Feb 1;133(2):389–399. doi: 10.1084/jem.133.2.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Moore C., Wallis C., Melnick J. L., Kuns M. D. Photodynamic treatment of herpes keratitis. Infect Immun. 1972 Feb;5(2):169–171. doi: 10.1128/iai.5.2.169-171.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Naib Z. M., Nahmias A. J., Josey W. E., Kramer J. H. Genital herpetic infection. Association with cervical dysplasia and carcinoma. Cancer. 1969 Apr;23(4):940–945. doi: 10.1002/1097-0142(196904)23:4<940::aid-cncr2820230432>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  15. Park J. H., Baron S. Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA. Science. 1968 Nov 15;162(3855):811–813. doi: 10.1126/science.162.3855.811. [DOI] [PubMed] [Google Scholar]
  16. Rawls W. E., Tompkins W. A., Figueroa M. E., Melnick J. L. Herpesvirus type 2: association with carcinoma of the cervix. Science. 1968 Sep 20;161(3847):1255–1256. doi: 10.1126/science.161.3847.1255. [DOI] [PubMed] [Google Scholar]
  17. Rawls W. E., Tompkins W. A., Melnick J. L. The association of herpesvirus type 2 and carcinoma of the uterine cervix. Am J Epidemiol. 1969 May;89(5):547–554. doi: 10.1093/oxfordjournals.aje.a120967. [DOI] [PubMed] [Google Scholar]
  18. Royston I., Aurelian L. The association of genital herpesvirus with cervical atypia and carcinoma in situ. Am J Epidemiol. 1970 Jun;91(6):531–538. doi: 10.1093/oxfordjournals.aje.a121164. [DOI] [PubMed] [Google Scholar]
  19. Ruskin J., McIntosh J., Remington J. S. Studies on the mechanisms of resistance to phylogenetically diverse intracellular organisms. J Immunol. 1969 Aug;103(2):252–259. [PubMed] [Google Scholar]
  20. SUTER E., RAMSEIAR H. CELLULAR REACTIONS IN INFECTION. Adv Immunol. 1964;27:117–173. doi: 10.1016/s0065-2776(08)60707-5. [DOI] [PubMed] [Google Scholar]
  21. Simon H. B., Sheagren J. N. Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity. J Exp Med. 1971 Jun 1;133(6):1377–1389. doi: 10.1084/jem.133.6.1377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Zisman B., Hirsch M. S., Allison A. C. Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice. J Immunol. 1970 May;104(5):1155–1159. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES